Boris Peaker analyst TD COWEN

Currently out of the existing stock ratings of Boris Peaker, 23 are a HOLD (46%), 27 are a BUY (54%).

Boris Peaker

Work Performance Price Targets & Ratings Chart

Analyst Boris Peaker works at TD COWEN with a stock forecast success ratio of 49.46% fulfilled within 150.13 days on average. Previously, Boris Peaker worked at OPPENHEIMER.

Boris Peaker’s has documented 93 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRK, Merck mpany at 04-Jan-2024.

Wall Street Analyst Boris Peaker

Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 6/19/2017. The price target of $54 was fulfilled within 8 days with a profit of $7.88 (12.73%) receiving and performance score of 15.92.

Average potential price target upside

CLDX Celldex Therapeutics EBS Emergent Biosolutions HRTX Heron Therapeuti SGEN Seagen IRWD Ironwood Pharmaceuticals JNCE Jounce Therapeutics AADI Aadi Bioscience CTMX CytomX Therapeutics NKTR Nektar Therapeutics MRK Merck mpany CTIC CTi Biopharma Corp PCRX Pacira Pharmaceuticals ADCT ADC Therapeutics SA

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

27

$-10.75 (-28.48%)

21

3 months 16 days ago

1/2 (50%)

$0.06 (0.22%)

4

Buy

80

$42.25 (111.92%)

73

3 months 20 days ago

1/8 (12.5%)

$50.65 (172.57%)

44

Buy

52

$14.25 (37.75%)

54

3 months 23 days ago

4/11 (36.36%)

$26.02 (100.15%)

61

Buy

68

$30.25 (80.13%)

70

6 months 15 days ago

0/3 (0%)

$37.77 (124.94%)

Buy

72

$34.25 (90.73%)

63

11 months 25 days ago

0/3 (0%)

$25.57 (55.07%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Boris Peaker is most bullish on?

Potential upside of $5.55 has been obtained for MRK (MERCK MPANY)

What Year was the first public recommendation made by Boris Peaker?

On 2011

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?